Terms: = Lymphoma AND ATP2B3, PMCA3, 492, ENSG00000067842
101 results:
1. [Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases].
Shen X; Yi HM; Li AQ; Ouyang BS; Dong L; Wang CF
Zhonghua Bing Li Xue Za Zhi; 2024 Jan; 53(1):29-33. PubMed ID: 38178743
[No Abstract] [Full Text] [Related]
2. Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party.
Penack O; Peczynski C; Koenecke C; Polge E; Sanderson R; Yakoub-Agha I; Fegueux N; Daskalakis M; Collin M; Dreger P; Kröger N; Schanz U; Bloor A; Ganser A; Besley C; Wulf GG; Novak U; Moiseev I; Schoemans H; Basak GW; Chabannon C; Sureda A; Glass B; Peric Z
Front Immunol; 2023; 14():1252811. PubMed ID: 37828980
[TBL] [Abstract] [Full Text] [Related]
3. Key factors associated with 6-thioguanine and 6-methylmercaptopurine nucleotide concentrations in children treated by thiopurine for acute leukaemia and inflammatory bowel disease.
de Beaumais TA; Lorrain S; Mamhoudi N; Simonin M; Martinez Vinson C; Medard Y; Petit A; Jacqz-Aigrain E
Br J Clin Pharmacol; 2024 Jan; 90(1):209-219. PubMed ID: 37621013
[TBL] [Abstract] [Full Text] [Related]
4. PI3K/AKT pathway-related microRNA variants in childhood acute lymphoblastic leukemia.
Xue Y; Sun X; Fu J; Rong L; Zhang H; Zhu Y; Yang X; Hu S; Chen J; Fang Y
Pediatr Blood Cancer; 2023 Oct; 70(10):e30545. PubMed ID: 37438860
[TBL] [Abstract] [Full Text] [Related]
5. Early Circulating Tumor DNA Dynamics and Efficacy of Lorlatinib in Patients With Treatment-Naive, Advanced, ALK-Positive NSCLC.
Soo RA; Martini JF; van der Wekken AJ; Teraoka S; Ferrara R; Shaw AT; Shepard D; Calella AM; Polli A; Toffalorio F; Tomasini P; Chiu CH; Kowalski DM; Kim HR; Solomon BJ
J Thorac Oncol; 2023 Nov; 18(11):1568-1580. PubMed ID: 37295609
[TBL] [Abstract] [Full Text] [Related]
6. Risk of malignant lymphomas in patients with inflammatory bowel disease: a population-based cohort study.
Yu J; Refsum E; Wieszczy P; Helsingen LM; Perrin V; Högdén A; Løberg M; Blom J; Bretthauer M; Adami HO; Ye W; Kalager M
BMJ Open Gastroenterol; 2023 May; 10(1):. PubMed ID: 37142293
[TBL] [Abstract] [Full Text] [Related]
7. Outcomes of Older Adults with Non-Hodgkin lymphoma Undergoing Autologous Stem Cell Transplantation: A Mayo Clinic Cohort Analysis.
Wudhikarn K; Johnson BM; Inwards DJ; Porrata LF; Micallef IN; Ansell SM; Hogan WJ; Paludo J; Villasboas JC; Johnston PB
Transplant Cell Ther; 2023 Mar; 29(3):176.e1-176.e8. PubMed ID: 36563788
[TBL] [Abstract] [Full Text] [Related]
8. Elevation of circulating TNF receptor 2 in cancer: A systematic meta-analysis for its potential as a diagnostic cancer biomarker.
Kartikasari AER; Cassar E; Razqan MAM; Szydzik C; Huertas CS; Mitchell A; Plebanski M
Front Immunol; 2022; 13():918254. PubMed ID: 36466914
[TBL] [Abstract] [Full Text] [Related]
9. BIA-ALCL Epidemiological Findings From a Retrospective Study of 248 Cases Extracted From Relevant Case Reports and Series: A Systematic Review.
Santanelli Di Pompeo F; Panagiotakos D; Firmani G; Sorotos M
Aesthet Surg J; 2023 Apr; 43(5):545-555. PubMed ID: 36441968
[TBL] [Abstract] [Full Text] [Related]
10. Association of antibiotic-consumption patterns with the prevalence of hematological malignancies in European countries.
Ternák G; Berényi K; Németh B; Szenczi Á; Márovics G; Kiss I
Sci Rep; 2022 May; 12(1):7821. PubMed ID: 35550556
[TBL] [Abstract] [Full Text] [Related]
11. Class I/Class II HLA Evolutionary Divergence Ratio Is an Independent Marker Associated With Disease-Free and Overall Survival After Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia.
Daull AM; Dubois V; Labussière-Wallet H; Venet F; Barraco F; Ducastelle-Lepretre S; Larcher MV; Balsat M; Gilis L; Fossard G; Ghesquières H; Heiblig M; Ader F; Alcazer V
Front Immunol; 2022; 13():841470. PubMed ID: 35309346
[TBL] [Abstract] [Full Text] [Related]
12. Association of Prognostic Understanding With Health Care Use Among Older Adults With Advanced Cancer: A Secondary Analysis of a Cluster Randomized Clinical Trial.
Loh KP; Seplaki CL; Sanapala C; Yousefi-Nooraie R; Lund JL; Epstein RM; Duberstein PR; Flannery M; Culakova E; Xu H; McHugh C; Klepin HD; Lin PJ; Watson E; Grossman VA; Liu JJ; Geer J; O'Rourke MA; Mustian K; Mohile SG
JAMA Netw Open; 2022 Feb; 5(2):e220018. PubMed ID: 35179585
[TBL] [Abstract] [Full Text] [Related]
13. Which surgical strategy for colorectal cancer with synchronous hepatic metastases provides the best outcome? A comparison between primary first, liver first and simultaneous approach.
Carbone F; Chee Y; Rasheed S; Cunningham D; Bhogal RH; Jiao L; Tekkis P; Kontovounisios C
Updates Surg; 2022 Apr; 74(2):451-465. PubMed ID: 35040077
[TBL] [Abstract] [Full Text] [Related]
14. Eruptive Seborrheic Keratoses Are Associated With a Co-Occurring Malignancy in the Majority of Reported Cases: A Systematic Review.
Mirali S; Mufti A; Lansang RP; Sachdeva M; Yeung J
J Cutan Med Surg; 2022; 26(1):57-62. PubMed ID: 34841905
[TBL] [Abstract] [Full Text] [Related]
15. An innovation in stem cell harvesting: Heparin use.
Gul HG; Erkurt MA; Sarici A; Kuku I; Kaya E; Berber I; Merter M; Bicim S; Ozgul M
Transfus Apher Sci; 2021 Oct; 60(5):103240. PubMed ID: 34404617
[TBL] [Abstract] [Full Text] [Related]
16. Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trial.
Yang W; Cai J; Shen S; Gao J; Yu J; Hu S; Jiang H; Fang Y; Liang C; Ju X; Wu X; Zhai X; Tian X; Wang N; Liu A; Jiang H; Jin R; Sun L; Yang M; Leung AWK; Pan K; Zhang Y; Chen J; Zhu Y; Zhang H; Li C; Yang JJ; Cheng C; Li CK; Tang J; Zhu X; Pui CH
Lancet Oncol; 2021 Sep; 22(9):1322-1332. PubMed ID: 34329606
[TBL] [Abstract] [Full Text] [Related]
17. Differences in lymphoma patients between chimeric antigen receptor T-cell therapy trials and the general population.
Apaydin EA; Richardson AS; Baxi S; Vockley J; Akinniranye O; Larkin J; Motala A; Hempel S
Clin Exp Med; 2022 Feb; 22(1):151-155. PubMed ID: 33997936
[TBL] [Abstract] [Full Text] [Related]
18. No association between relapse hazard and thiopurine methyltransferase geno- or phenotypes in non-high risk acute lymphoblastic leukemia: a NOPHO ALL2008 sub-study.
Nielsen SN; Toksvang LN; Grell K; Nersting J; Abrahamsson J; Lund B; Kanerva J; Jónsson ÓG; Vaitkeviciene G; Pruunsild K; Appell ML; Hjalgrim LL; Schmiegelow K
Cancer Chemother Pharmacol; 2021 Aug; 88(2):271-279. PubMed ID: 33928426
[TBL] [Abstract] [Full Text] [Related]
19. Adolescents and young adult acute myeloid leukemia outcomes at pediatric versus adult centers: A population-based study.
Gupta S; Baxter NN; Sutradhar R; Pole JD; Nagamuthu C; Lau C; Nathan PC
Pediatr Blood Cancer; 2021 Aug; 68(8):e28939. PubMed ID: 33559361
[TBL] [Abstract] [Full Text] [Related]
20. Screening for monoclonal B-lymphocyte expansion in a hospital-based Chinese population with lymphocytosis: an observational cohort study.
Xu J; Li J; Wei Z; Wang Y; Liu P
BMJ Open; 2020 Sep; 10(9):e036006. PubMed ID: 32933958
[TBL] [Abstract] [Full Text] [Related]
[Next]
